🇺🇸 AMGN — Amgen Inc.

Salud Mantener
← Volver

Precio actual

460,42 USD

Máx. histórico

478,48

2 días

Split 2:1 del 22/11/1999

Caída desde máximo

-3,77%

Rango 52 semanas

312,39 – 483,99

Variación hoy

+0,03%

Cierre anterior

460,28

Rango de hoy

447,04 – 462,91

Volumen hoy

2.578.799

Peor caída histórica

-78,03%

17/06/1983 → 19/11/1984

Recuperado en 487 días

Volatilidad anualizada ⓘ

37,46%

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
26,69 (puede no estar actualizado)
Dividend yield
2,19% (puede no estar actualizado)
Precio objetivo analistas
409,63 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,16%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/10/2015 138,26 142,54 135,64 142,47 +1,60% 4,99% 4.803.500
01/10/2015 138,55 140,64 136,60 140,23 +1,38% 2,92% 4.675.900
30/09/2015 136,66 139,25 135,86 138,32 +3,36% 2,48% 6.209.500
29/09/2015 132,00 138,00 131,43 133,82 +1,19% 4,98% 6.251.500
28/09/2015 137,99 138,19 130,09 132,24 -4,54% 5,87% 7.514.700
25/09/2015 146,06 146,75 136,76 138,53 -3,47% 6,84% 5.243.700
24/09/2015 144,72 145,63 141,36 143,51 -1,52% 2,95% 3.519.200
23/09/2015 146,08 147,04 144,03 145,72 -0,14% 2,06% 2.785.400
22/09/2015 145,00 146,78 142,82 145,93 -0,79% 2,73% 4.518.000
21/09/2015 151,97 152,80 146,32 147,09 -2,32% 4,26% 4.702.600
18/09/2015 151,12 153,37 149,03 150,59 -2,16% 2,87% 6.487.300
17/09/2015 151,70 156,34 151,00 153,91 +1,81% 3,52% 3.519.500
16/09/2015 151,97 152,88 148,47 151,18 -0,63% 2,90% 4.004.200
15/09/2015 152,02 152,79 150,24 152,14 +0,75% 1,68% 2.560.200
14/09/2015 153,89 153,89 150,05 151,00 -1,44% 2,50% 2.896.200
11/09/2015 152,05 153,45 150,93 153,21 +0,05% 1,66% 2.422.700
10/09/2015 150,84 154,32 150,56 153,14 +1,36% 2,49% 3.477.900
09/09/2015 156,19 156,76 150,62 151,08 -2,25% 3,93% 2.987.600
08/09/2015 151,60 154,66 151,00 154,56 +5,13% 2,41% 4.508.400
04/09/2015 147,49 148,96 145,75 147,02 -1,48% 2,18% 3.362.800
03/09/2015 152,68 154,12 148,93 149,23 -2,01% 3,40% 2.868.400
02/09/2015 149,07 152,35 147,25 152,29 +3,28% 3,42% 4.339.100
01/09/2015 149,23 150,99 146,95 147,46 -2,85% 2,71% 5.523.000
31/08/2015 155,33 156,35 151,30 151,78 -2,64% 3,25% 4.354.500
28/08/2015 156,38 158,00 153,71 155,89 +0,11% 2,74% 4.649.300
27/08/2015 154,88 157,10 151,36 155,72 +1,13% 3,71% 4.910.500
26/08/2015 151,23 154,11 147,13 153,98 +6,05% 4,62% 5.251.300
25/08/2015 152,50 153,88 144,88 145,19 -1,66% 5,90% 6.701.100
24/08/2015 145,33 154,42 140,00 147,64 -4,87% 9,92% 8.697.500
21/08/2015 158,97 163,92 155,19 155,19 -3,70% 5,49% 6.208.400